SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Intensive Care Medicine
This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Antezano, E. S.
Right arrow Articles by Hong, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Antezano, E. S.
Right arrow Articles by Hong, M.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Sudden Cardiac Death

Eduardo S. Antezano, MD

Mauricio Hong, MD

Division of Cardiology, M/C 7872, University of Texas Health Science Center, 7703 Floyd Curl Dr, San Antonio, TX 78229

Sudden cardiac death (SCD) due to ventricular tachyarrhythmias is a leading cause of death in the United States. This phenomenon is associated with coronary artery disease, valvular heart disease, nonischemic cardiomyopathies, congenital heart disease, primary electrical abnormalities, autonomic nervous system abnormalities, and other less common disorders. Evaluation and management of patients at risk for SCD (primary prevention) and of patients who have survived at least 1 episode of SCD (secondary prevention) have evolved in recent years because clinical trials have shown consistent benefit from implantation of cardioverter-defibrillators in appropriately selected patients. An evidence-based approach to primary and secondary prevention of SCD is presented.

Key Words: sudden cardiac death • cardiac arrest • amiodarone • sotalol • implantable cardioverter-defibrillator

References

  • 1. Pinto DS, Josephson ME. Sudden cardiac death. In: Fuster V, ed. Hurst’s The Heart. New York: McGraw-Hill; 2001:1015-1048.
  • 2. Myerburg RJ, Castellanos A. Cardiac arrest and sudden cardiac death. In: Braunwald E, ed. Heart Disease: A Textbook of Cardiovascular Medicine. Philadelphia: W. B. Saunders; 2001:890-931.
  • 3. Gillum RF, Folsom A, Luepker RV, et al. Sudden death and acute myocardial infarction in a metropolitan area, 1970-1980: the Minnesota Heart Survey. N Engl J Med. 1983;309:1353-1380.[Abstract]
  • 4. Gillum RF. Sudden coronary death in the United States 1980-1985. Circulation. 1989;79:756-765.[Abstract/Free Full Text]
  • 5. Gillum RF. Sudden cardiac death in Hispanic Americans and African Americans. Am J Public Health. 1997;87:1461-1466.[Abstract/Free Full Text]
  • 6. Zheng et al. State-Specific Mortality From Sudden Cardiac Death—United States 1999. MMWR. 2002;51(6):123-126.[Medline] [Order article via Infotrieve]
  • 7. Podrid PJ, Kovey PR, eds. Cardiac Arrhythmia: Mechanisms, Diagnosis, and Management. 2nd ed. Baltimore: Williams & Wilkins; 1995.
  • 8. Takata TS, Page RL, Joglar JA. Automated external defibrillators: technical considerations and clinical promise. Ann Intern Med. 2001;135:990-998.[Abstract/Free Full Text]
  • 9. The American Heart Association in Collaboration with the International Liaison Committee on Resuscitation. Guidelines 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Part 4: the automated external defibrillator: key link in the chain of survival.Circulation. 2000;102:I60-I76.[Medline] [Order article via Infotrieve]
  • 10. Bayes de Luna A, Coumel P, Leclercq JF. Ambulatory sudden cardiac death: mechanisms of production of fatal arrhythmia on the basis of data from 157 cases. Am Heart J. 1989;117:151-159.[CrossRef][Medline] [Order article via Infotrieve]
  • 11. Kannel WB, Cupples LA, D’Agostino RB. Sudden death risk in overt coronary heart disease: the Framingham Study. Am Heart J. 1987;113:799-804.[CrossRef][Medline] [Order article via Infotrieve]
  • 12. Zipes DP, Wellens HJJ. Sudden cardiac death. Circulation. 1998;98:2334-2351.[Free Full Text]
  • 13. Weaver WD, Lorch GS, Alvarez HA, et al. Angiographic findings and prognostic indicators in patients resuscitated from sudden cardiac death. Circulation. 1976;54:895-900.[Abstract/Free Full Text]
  • 14. Perper JA, Kuller LH, Cooper M. Arteriosclerosis of coronary arteries in sudden unexpected deaths. Circulation. 1975;52(suppl 6):III27-III33.[Medline] [Order article via Infotrieve]
  • 15. Theroux P, Fuster V. Acute coronary syndromes: unstable angina and non-Q-wave myocardial infarction. Circulation. 1998;97:1195-1206.[Free Full Text]
  • 16. Huikuri HV, Castellanos A, Myerburg RJ. Sudden death due to cardiac arrhythmias. N Engl J Med. 2001;345:1473-1482.[Free Full Text]
  • 17. Basso C, Corrado D, Thiene G. Congenital coronary artery anomalies as an important cause of sudden death in the young. Card in Review. 2001;9:312-317.[CrossRef]
  • 18. Schwartz PJ, La Rovere MT, Vanoli E. Autonomic nervous system and sudden cardiac death: experimental basis and clinical observations for post-myocardial infarction risk stratification. Circulation. 1992;85(suppl I):I77-I91.[Medline] [Order article via Infotrieve]
  • 19. Corrado D, Thiene G, Cocco P, et al. Non-atherosclerotic coronary artery disease and sudden death in the young. Br Heart J. 1992;68:601-607.[Abstract/Free Full Text]
  • 20. Narasimhan C, Jazayeri MR, Sra J, et al. Ventricular tachycardia in valvular heart disease: facilitation of sustained bundle-branch reentry by valve surgery. Circulation. 1997;96:4307-4313.[Abstract/Free Full Text]
  • 21. Blackstone EH, Kriklin JW. Death and time related events after valve replacement. Circulation. 1985;74:753-767.
  • 22. Tamburro P, Wilber D. Sudden death in idiopathic dilated cardiomyopathy. Am Heart J. 1992;124:1035-1045.[CrossRef][Medline] [Order article via Infotrieve]
  • 23. Spirito P, Seidman CE, McKenna WJ, Maron BJ. The management of hypertrophic cardiomyopathy. N Engl J Med. 1997;336:775-785.[Free Full Text]
  • 24. Mckenna W, Behr ER. Hypertrophic cardiomyopathy: management, risk stratification, and prevention of sudden death. Heart. 2002;87:169-176.[Free Full Text]
  • 25. Elliot PM, Gimeno BJ, Mahon NG, et al. Relation between severity of left ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy. Lancet. 2001;357:420-424.[CrossRef][Medline] [Order article via Infotrieve]
  • 26. Corrado D, Basso C, Thiene G, et al. Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study. J Am Coll Cardiol. 1997;30:1512-1520.[Abstract]
  • 27. Gatzoulis MA, Till JA, Somerville J, Redington A. Mechanoelectrical interaction in tetralogy of Fallot: QRS prolongation relates to right ventricular size and predicts malignant ventricular arrythmias and sudden death. Circulation. 1997;95:231-237.[Abstract/Free Full Text]
  • 28. Theleman KP, Kuiper JJ, Roberts WC. Acute myocarditis (predominately lymphocytic) causing sudden death without heart failure. Am J Cardiol. 2001;88:1078-1083.[CrossRef][Medline] [Order article via Infotrieve]
  • 29. Maron BJ, Poliac LC, Kaplan JA, et al. Blunt impact to the chest leading to sudden death from cardiac arrest during sports activities. N Engl J Med. 1995;333:337-337.[Abstract/Free Full Text]
  • 30. Zareba W, Moss AJ, Schwartz PJ, et al. Influence of the genotype on the clinical course of the long QT syndrome. N Engl J Med. 1998;339:960-965.[Abstract/Free Full Text]
  • 31. Ananthasubramaniam K, Khaja F. Arrhythmogenic right ventricular dysplasia/cardiomyopathy: review for the clinician. Prog Cardiovasc Dis. 1998;41:237-246.[CrossRef][Medline] [Order article via Infotrieve]
  • 32. Spirito P, Bellone P, Harris KM, Bernabo P, Bruzzi P, Maron BJ. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med. 2000;342:1778-1785.[Abstract/Free Full Text]
  • 33. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a dis-tinct clinical and electrocardiographic syndrome: a multicenter report. J Am Coll Cardiol. 1992;20:1391-1396.[Abstract]
  • 34. Farrell TG, Bashir Y, Cripps T, et al. Risks stratification for arrhythmic events in postinfarction patients based on heart rate variability, ambulatory electrocardiographic variables and the signal-averaged electrocardiogram. J Am Coll Cardiol. 1991;18:687-697.[Abstract]
  • 35. Ikeda T, Saito H, Tanno K, et al. T-wave alternans as a predictor for sudden cardiac death after myocardial infarction. Am J Cardiol. 2002;89:79-82.[CrossRef][Medline] [Order article via Infotrieve]
  • 36. Breithardt G, Cain ME, el-Sherif N, et al. Standards for analysis of ventricular late potentials using high resolution or signal-averaged electrocardiography: a statement by a Task Force Committee between the European Society of Cardiology, the American Heart Association and the American College of Cardiology. Eur Heart J. 1991;12:473-480.[Abstract/Free Full Text]
  • 37. El-Sherif N, Denes P, Katz R, et al. Definition of the best prediction criteria of the time-domain signal-averaged electrocardiogram for serious arrhythmic events in the postinfarction period. J Am Coll Cardiol. 1995;25:908-914.[Abstract]
  • 38. A randomized trial of propanolol in patients with acute myocardial infarction. I. Mortality results. JAMA. 1982;247:1707-1714.[Abstract/Free Full Text]
  • 39. Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis. 1985;27:335-371.[Medline] [Order article via Infotrieve]
  • 40. Echt DS, Liebson PR, Mitchell LB, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo: the Cardiac Arrhythmia Suppression Trial. N Engl J Med. 1991;324:781-788.[Abstract]
  • 41. Waldo AL, Camm AJ, deRuyter H, et al. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. Lancet. 1996;348:7-12.[CrossRef][Medline] [Order article via Infotrieve]
  • 42. Doval HC, Nul DR, Grancelli HO, et al. Randomized trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA). Lancet. 1994;344:493-498.[CrossRef][Medline] [Order article via Infotrieve]
  • 43. Singh SN, Fletcher RD, Fisher SG, et al. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. N Engl J Med. 1995;333:77-82.[Abstract/Free Full Text]
  • 44. Cairns JA, Connolly SJ, Roberts R, et al. for the Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators. Randomized trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarizations: CAMIAT. Lancet. 1997;349:675-682.[CrossRef][Medline] [Order article via Infotrieve]
  • 45. Julian DG, Camm AJ, Frangin G, et al. Randomized trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction. EMIAT. European Myocardial Infarct Amiodarone Trial Investigators. Lancet. 1997;349:667-674.[CrossRef][Medline] [Order article via Infotrieve]
  • 46. Kober L, Bloch Thompsem PE, Moller M, et al. Randomized trial of effect of dofetilide in patients with recent myocardial infarction and left ventricular dysfunction. DIAMOND. The Danish Investigators of Arrhythmia and Mortality on Dofetilide. Clin Cardiol. 1997;20:704-710.[Medline] [Order article via Infotrieve]
  • 47. Exner DV, Klein GJ, Prystowsky EN. Primary prevention of sudden death with implantable defibrillator therapy in patients with cardiac disease. Can we afford to do it? (Can we afford not to?) Circulation. 2001;104:1564-1570.[Free Full Text]
  • 48. Leon Greene H. The implantable cardioverter-defibrillator.Clin Cardiol. 2000;23:315-326.[Medline] [Order article via Infotrieve]
  • 49. Pristowsky EN. Primary and secondary prevention of sudden cardiac death: the role of the implantable cardioverter defibrillator. Rev Cardiovasc Med. 2001;2(4):197-205.[CrossRef][Medline] [Order article via Infotrieve]
  • 50. Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia: Multicenter Automatic Defibrillator Implantation Trial (MADIT) Investigators. N Engl J Med. 1996;335:1933-1940.[Abstract/Free Full Text]
  • 51. Bigger JT. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery: Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. N Engl J Med. 1997;337:1569-1575.[Abstract/Free Full Text]
  • 52. Bansch D, Antz M, Boczor S, et al. Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy. The Cardiomyopathy Trial (CAT). Circulation. 2002;105:1453-1458.[Abstract/Free Full Text]
  • 53. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease: Multicenter Unsustained Tachycardia Trial (MUSTT) Investigators. N Engl J Med. 1999;341:1882-1890.[Abstract/Free Full Text]
  • 54. Buxton AE, Lee KL, DiCarlo L, et al. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial (MUSTT) Investigators. N Engl J Med.2000;342:1937-1945.[Abstract/Free Full Text]
  • 55. Moss AJ, Zareba W, Hackson Hall W, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. Multicenter Automatic Defibrillator Implantation Trial II (MADIT II) Investigators. N Engl J Med. 2002;346:877-883.[Abstract/Free Full Text]
  • 56. Gregoratos G, Abrams J, Epstein AE, et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices— summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). J Am Coll Cardiol. 2002;40:1703-1719.[Free Full Text]
  • 57. Salukhe TV, Francis DP, Sutton R. Comparison of medical therapy, pacing and defibrillation in heart failure (COMPANION) trial terminated early; combined biventricular pacemaker-defibrillators reduce all-cause mortality and hospitalization. Int J Cardiol. 2003;87(2-3):119-120.[CrossRef][Medline] [Order article via Infotrieve]
  • 58. Mason JW, the ESVEM Investigators. A comparison of electrophysiologic testing with Holter monitoring to predict antiarrhythmic-drug efficacy for ventricular tachyarrhythmias. N Engl J Med. 1993;329:445-451.[Abstract/Free Full Text]
  • 59. The CASCADE Investigators. Randomized antiarrhythmic drug therapy in survivors of cardiac arrest (the CASCADE Study). Am J Cardiol. 1993;72:280-287.[CrossRef][Medline] [Order article via Infotrieve]
  • 60. The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med. 1997;337:1576-1583.[Abstract/Free Full Text]
  • 61. Connolly SJ, Gent M, Robert RS, et al. Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation. 2000;101:1297-1302.[Abstract/Free Full Text]
  • 62. Kuck KH, Cappato R, Siebels J, et al. Randomized comparison of anti-arrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation. 2000;102:748-754.[Abstract/Free Full Text]
  • 63. Strobel JS, Epstein AE. Large clinical trials in the management of ventricular arrhythmias. Cardiol Clin. 2000; 18(2):337-356.[CrossRef][Medline] [Order article via Infotrieve]
  • 64. Sweeney MO, Ellison KE, Stevenson WG. Implantable cardioverter defibrillators in heart failure. Cardiol Clin. 2001;19(4):653-667.[CrossRef][Medline] [Order article via Infotrieve]
  • 65. Schron EB, Exner DV, Yao Q, et al. Quality of life in the antiarrhythmics versus implantable defibrillators trial: impact of therapy and influence of adverse symptoms and defibrillator shocks. Circulation. 2002;105(5):589-594.[Abstract/Free Full Text]
  • 66. Kuppermann M, Luce BR, McGovern B, et al. An analysis of the cost effectiveness of the implantable defibrillator. Circulation. 1990;81:91-100.[Abstract/Free Full Text]
  • 67. Larsen GC, Hallstrom A, McAnulty J, et al. Cost-effectiveness of the implantable cardioverter-defibrillator versus antiarrhythmic drugs in survivors of serious ventricular tachyarrhythmias. Results of the AVID economic analysis substudy. Circulation. 2002;105:2049-2057.[Abstract/Free Full Text]
  • 68. Owens DK, Sanders GD, Harris RA, et al. Cost-effectiveness of implantable cardioverter defibrillators relative to amiodarone for prevention of sudden cardiac death. Ann Intern Med. 1997;126:1-12.[Abstract/Free Full Text]
  • 69. Mushlin AI, Hall WJ, Zwanziger J, et al. The cost-effectiveness of automatic implantable cardiac defibrillators: results from MADIT. Circulation. 1998;97:2129-2135.[Abstract/Free Full Text]
  • 70. O’Brien BJ, Connolly ST, Goeree R, et al, for the CIDS Investigators. Cost-effectiveness of the implantable cardioverterdefibrillator: results from the Canadian Implantable Defibrillator Study (CIDS). Circulation. 2001;103:1416-1421.[Abstract/Free Full Text]
  • 71. Sheldon R, O’Brien BJ, Blackhouse G, et al. Effect of clinical risk stratification on cost-effectiveness of the implantable cardioverter-defibrillator. The Canadian Implantable Defibrillator Study. Circulation. 2001;104:1622-1626.[Abstract/Free Full Text]
  • 72. Larsen G, Hallstrom A, McAnulty J, Pinski S, et al. Cost effectiveness of the implantable cardioverter-defibrillator versus antiarrhythmic drugs in survivors of serious ventricular tachyarrhythmias. Results of the Antiarrhythmic Versus Implantable Defibrillators (AVID) economic analysis substudy. Circulation. 2002;105:2049-2057.[Abstract/Free Full Text]
  • 73. Lysaght MJ. Maintenance dialysis population dynamics: current trends and long-term implications. J Am Soc Nephrol. 2002;13(suppl 1):S37-S40.[Abstract/Free Full Text]
  • 74. Harrison EE. Lidocaine in prehospital countershock refractory ventricular fibrillation. Ann Emerge Med. 1981;10:420-423.
  • 75. Kudenchuk PJ, Cobb LA, Copass MK, et al. Amiodarone in Out-of-Hospital Resuscitation of Refractory Sustained Ventricular Tachyarrhythmias (ARREST) Trial. N Engl J Med. 1999;341:871-878.[Abstract/Free Full Text]

Journal of Intensive Care Medicine, Vol. 18, No. 6, 313-329 (2003)
DOI: 10.1177/0885066603258140
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Antezano, E. S.
Right arrow Articles by Hong, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Antezano, E. S.
Right arrow Articles by Hong, M.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Advertisement